Annexon Biosciences

Founded in 2011 and headquartered in South San Francisco, California, Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company operating in the biotechnology research industry. With more than 110 employees, the company is developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders affecting the body, brain, and eye. Its pipeline is built on a proprietary platform targeting diseases triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is advancing several innovative candidates designed to block C1q and the broader classical complement pathway, including ANX005, administered intravenously, ANX007, delivered intravitreally, and ANX009, given subcutaneously. The company follows a disciplined, biomarker-driven approach intended to improve the probability of technical success across its portfolio.

• 

  Annexon Biosciences

  2 months ago

  Senior director, global scientific communications

  remote, CA, United States

  $290k – $320k/yrFull TimeDirector

  Apply
• 

  Annexon Biosciences

  4 months ago

  Senior director, regulatory affairs

  onsite, Brisbane, CA, United States

  $216k – $241k/yrFull TimeDirector

  Apply
• 

  Annexon Biosciences

  5 months ago

  Senior director, medical writing

  onsite, Brisbane, CA, United States

  $257k – $286k/yrFull TimeDirector

  Apply
• 

  Annexon Biosciences

  5 months ago

  Senior director, medical writing

  onsite, Brisbane, CA, United States

  $257k – $286k/yrFull TimeDirector

  Apply
• 

  Annexon Biosciences

  5 months ago

  Associate director, clinical trial management

  onsite, Brisbane, CA, United States

  $179k – $200k/yrFull TimeDirector

  Apply

Hiring activity at Annexon Biosciences